Neuroradiology: Page 36

Can AI enable 90% lower gadolinium dose in brain MRI?

By Erik L. Ridley

Thursday, December 2 | 9:30 a.m.-10:30 a.m. | SSNR14-2 | Room E353BAn artificial intelligence (AI) algorithm can enable high-quality contrast-enhanced brain MRI exams to be acquired using only 10% of the normal dose of a gadolinium-based contrast agent, according to this multicenter clinical study.

November 23, 2021

Deep learning boosts spine MRI performance

By Kate Madden Yee

Wednesday, December 1 | 8:00 a.m.- 9:00 a.m. | SSNR11-2 | Room E351Adding deep learning to spine MRI improves image quality, which may translate to better patient experiences and imaging efficacy, according to study results to be shared at the RSNA meeting.

November 23, 2021

MRI scans show how autism affects young brains over time

By Kate Madden Yee

Researchers from Yale University have found that autism affects the microstructure of white matter in the brains of adolescents and young adults over time as indicated on MRI scans. The study results are being presented at the upcoming RSNA 2021 meeting.

November 22, 2021

PET/CT classifies subtypes in progressive nuclear palsy

By Will Morton

Monday, November 29 | 3:00 p.m.-4:00 p.m. | SSNMMI04-4 | Room S405In this session on brain imaging, researchers from India will present a study that elucidates patterns of characteristic hypometabolism on F-18 FDG PET/CT in various subtypes of progressive nuclear palsy and their correlation with core clinical features.

November 22, 2021

fMRI shows multiple concussions can affect teen brains

By Kate Madden Yee

Functional MRI (fMRI) shows that adolescents and young adults who have sustained three to five concussions have disrupted brain connectivity in their default mode network, according to study results being presented at the RSNA 2021 meeting in Chicago.

November 21, 2021

MRI sheds light on effects of aducanumab Alzheimer's drug

By Kate Madden Yee

Researchers have found that MRI helps evaluate the effects of Alzheimer's treatment with the drug aducanumab -- sold commercially as Aduhelm -- and adjust or suspend dosage if needed, according to a study published November 22 in JAMA Neurology.

November 21, 2021

Deep-learning algorithm triages emergency head CTs

By Erik L. Ridley

Wednesday, December 1 | 1:30 p.m.-2:30 p.m. | SSMS05-3 | Room TBAA deep-learning algorithm trained on only normal head CT exams can triage emergency cases for priority review by radiologists, according to this presentation.

November 17, 2021

Viz.ai debuts AI-based brain aneurysm tool at SVIN 2021

By AuntMinnie.com staff writers

Artificial intelligence (AI) software company Viz.ai has debuted new cerebral aneurysm detection software at the Society of Vascular and Interventional Neurology (SVIN) 2021 annual meeting in Phoenix.

November 16, 2021

FDA clears neuroimaging software from Advantis

By AuntMinnie.com staff writers

The U.S. Food and Drug Administration (FDA) has cleared Advantis Medical Imaging's Brainance MD neuroimaging software platform for analyzing brain MRI exams.

November 15, 2021

Report: Reimbursement drives adoption of AI software for stroke

By Erik L. Ridley

The start in 2020 of Medicare payments for artificial intelligence (AI) software to detect large-vessel occlusion stroke on CT scans has precipitated a sharp increase in utilization, according to a new report from group purchasing organization Vizient.

November 14, 2021

Deep learning meets need for speed in spine MRI

By Erik L. Ridley

Thursday, December 2 | 9:30 a.m.-10:30 a.m. | SSNR14-5 | Room TBAIn this session, researchers will show how a deep learning-based image reconstruction method can deliver up to 72% faster spine MRI scan times along with perceived improvements in image quality.

November 14, 2021

Can AI enable 90% lower gadolinium dose in brain MRI?

By Erik L. Ridley

Thursday, December 2 | 9:30 a.m.-10:30 a.m. | SSNR14-2 | Room TBAAn artificial intelligence (AI) algorithm can enable high-quality contrast-enhanced brain MRI exams to be acquired using only 10% of the normal dose of a gadolinium-based contrast agent, according to this multicenter clinical study.

November 14, 2021

Previous Page

Page 36 of 238

Next Page